News EVERSANA buys digital drug-price marketplace firm Waltz Heal... EVERSANA has acquired Waltz Health, a Chicago digital health company offering AI-driven marketplaces to lower overall drug costs.
Views & Analysis Can AI agents reimagine pharma marketing from the ground up? At an invite-only event last week on Google's campus, EVERSANA made its pitch for re-imagining pharma marketing in the age of AI.
News EVERSANA unveils industry's 'first AI marketing agency' EVERSANA has ramped up the application of artificial intelligence to pharma marketing with the launch of The AI Agency.
News EVERSANA unveils new AI-powered pharmacovigilance suite EVERSANA has launched a new pharmacovigilance platform to answer the need for advanced analytics and AI in drug safety monitoring and risk management.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.